FDA Commissioner McClellan Named to Head CMS

March 1, 2004

1 Min Read
FDA Commissioner McClellan Named to Head CMS

Originally Published MX March/April 2004

BUSINESS NEWS

Mark B. McClellan

In mid-February, President Bush nominated FDA commissioner Mark B. McClellan, MD, PhD, to become the next administrator of the Centers for Medicare and Medicaid Services (CMS; Baltimore). Responding in near-record time, the full Senate approved the nomination on March 12. The confirmation puts McClellan in charge of the agency responsible for the healthcare of 40 million Medicare recipients and an additional 44 million beneficiaries in the federal-state Medicaid program. CMS outlays over the next fiscal year will be $482 billion.

The medtech industry responded very favorably to the news, particularly in regard to the potential for addressing reimbursement issues, which are now typically of much greater concern than the FDA approval process.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like